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Introduction
Cyclin E, an activator of cyclin-dependent kinase (Cdk) 2, accu-
mulates at the G1/S boundary of the cell cycle, where it stimu-
lates functions associated with entry into and progression through 
S phase (Resnitzky et al., 1994; Ohtsubo et al., 1995; Sauer and 
Lehner, 1995; Ekholm and Reed, 2000). Normally, cyclin E levels 
are tightly regulated so that peak cyclin E–Cdk2 kinase activity 
occurs only for a short interval near the G1/S boundary (Ekholm 
and Reed, 2000). This is accomplished primarily by the peri-
odic E2F-dependent transcription of cyclin E during late G1 
phase (Koff et al., 1991; Dulic et al., 1992) and its subsequent 
phosphorylation-dependent ubiquitin-mediated proteolysis in S 
phase when cyclin E–Cdk2 complexes become active (Strohmaier 
et al., 2001). Cyclin E expression and activation of Cdk2 at the 
G1/S boundary are compatible with the known roles of cyclin E 
in the promotion of replication-associated functions (Arata et al., 
2000; Geng et al., 2003; Ekholm-Reed et al., 2004a; Mailand 
and Diffl  ey, 2005).
The overexpression of cyclin E has been observed in a 
broad spectrum of human malignancies, suggesting that proper 
regulation of cyclin E is important for the preservation of nor-
mal cellular functions (Keyomarsi et al., 1995; Sandhu and 
Slingerland, 2000; Spruck et al., 2002; Erlandsson et al., 2003; 
Ekholm-Reed et al., 2004b). Under such circumstances, cyclin E 
is often expressed at levels higher than those observed in nor-
mal tissues, but also the periodic expression at the G1/S bound-
ary is frequently lost, with cyclin E levels maintained throughout 
the cell cycle. This can occur through a single mutation in Cdc4 
(also known as Fbw7), the F-box component of an SCF (Skp1-
Cul1–F-box protein) ubiquitin ligase that targets cyclin E for 
ubiquitin-mediated degradation (Strohmaier et al., 2001; Spruck 
et al., 2002; Rajagopalan et al., 2004). Furthermore, the over-
expression of cyclin E in some cancers has been associated with 
aggressive disease and poor outcome (Dutta et al., 1995; Porter 
et al., 1997; Nielsen et al., 1998; Erlanson and Landberg, 2001; 
Keyomarsi et al., 2002). A direct causal link between cyclin E 
overexpression and tumorigenesis is supported by a transgenic 
mouse model in which the ectopic expression of cyclin E in the 
mammary epithelium induces mammary carcinogenesis (Bortner 
and Rosenberg, 1997; Smith et al., 2006).
The basis for cyclin E–induced tumorigenesis remains 
controversial. Because cyclin E, by virtue of its ability to acti-
vate Cdk2, is a positive regulator of the cell cycle, it has been 
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proposed that the role of cyclin E in tumorigenesis is to stimu-
late cellular proliferation (Geng et al., 2003). This is consistent 
with the role of cyclin E–Cdk2 in phosphorylating and inacti-
vating the retinoblastoma protein Rb, a negative regulator of 
proliferation (Lukas et al., 1997; Harbour et al., 1999; Zhang 
et al., 1999). Furthermore, the ectopic expression of cyclin E was 
shown to drive cultured cells from G1 into S phase with acceler-
ated kinetics (Ohtsubo and Roberts, 1993; Resnitzky et al., 
1994). However, in these studies, the overall rate of prolifera-
tion was not altered, arguing against a direct link between cyclin E 
overexpression and increased proliferation in the context of 
tumorigenesis. On the other hand, cyclin E–mediated mammary 
hyperplasia was observed in mice carrying a mammary epithe-
lium–specifi  c cyclin E transgene, which is consistent with a link 
between cyclin E overexpression and cellular proliferation 
in vivo (Bortner and Rosenberg, 1997).
An alternative view of the role of cyclin E overexpression 
in tumorigenesis comes from a study of genomic instability 
(Spruck et al., 1999). In cultured nontransformed cells, the 
overexpression of cyclin E led to both chromosome instabil-
ity and polyploidy (Spruck et al., 1999). Chromosome instabil-
ity was a relatively infrequent event under moderate levels 
of cyclin E overexpression but was manifest reproducibly as 
both chromosome losses and gains, suggesting nondisjunction 
or other mitotic aberrations as possible mechanisms. Polyploidy 
was a more frequent event that was easily scorable under the 
experimental conditions. Polyploid cells, which are themselves 
unstable, can readily give rise to aneuploidy (Thiagalingam 
et al., 2000). Cyclin E overexpression in a tissue culture model 
has also been associated with the formation of micronuclei, 
which is suggestive of the generation of aneuploid cells 
(Rajagopalan et al., 2004). Genomic instability in the forms of 
both chromosome instability and polyploidy, leading to aneu-
ploidy, could easily explain the link between cyclin E overex-
pression and tumorigenesis.
Genomic instability has been shown to promote tumori-
genesis on several levels, most notably by facilitating the loss of 
heterozygosity at tumor suppressor loci and amplifi  cation of on-
cogenes (Thiagalingam et al., 2000). Consistent with this inter-
pretation, early loss of the heterozygosity of the tumor suppressor 
gene encoding p53 was observed in the mouse mammary cyclin E 
transgenic model (Smith et al., 2006). Importantly, both aneu-
ploidy and polyploidy have been observed in human tumors in 
which cyclin E is overexpressed (Hubalek et al., 2004).
In terms of the mechanism whereby cyclin E overexpres-
sion promotes genomic instability, cell cycle analysis has pro-
vided several clues. Early studies indicated that the ectopic 
expression of cyclin E, although accelerating entry into S phase, 
caused a substantial prolongation of S phase (Ohtsubo and 
Figure 1.  Cyclin E overexpression and elevated kinase activity leads to an 
accumulation of S and G2/M populations. (a) Western blot comparing the 
expression of cyclin E in KB cells 24 h after transduction with an adeno-
virus expressing WT cyclin E (ad cyclin E) or with empty vector (EV control). 
(b) Histone H1 kinase assay of cyclin E–Cdk2 from M-phase enriched cells. 
KB cells were transduced with cyclin E or EV control adenovirus and weren 
enriched for mitotic cells using a single thymidine block followed by an 8-h 
release in the presence of nocodazole. Cell lysates were immunoprecipi-
tated with anti-Cdk2, and the immune complexes were subjected to an in 
vitro kinase assay using puriﬁ  ed histone H1 as a substrate. (c) Cell cycle 
analysis of adenovirus-transduced KB cells by 2D ﬂ   ow cytometry. Asyn-
chronous KB cells were transduced with cyclin E or EV control adenovirus 
for 24 h followed by a 20-min incubation with BrdU and were stained with 
propidium iodide to determine the DNA content and with anti-BrdU anti-
body to resolve the S-phase population. (d) Comparison of cyclin E levels 
during the cell cycle between adenovirally transduced cell lines used in this 
study (KB, IME, and U2OS) and breast cancer–derived cell lines expressing 
high levels of cyclin E (MDA-MB-157 and SUM149-PT). All adenoviral trans-
ductions were performed as described in Materials and methods. Trans-
duced and untransduced cells were subjected to a single thymidine block 
and release as described in Materials and methods. Cells were collected 
at the thymidine block and then at 8, 12, and 14 h to ﬁ  nd the point with 
the maximum percentage of cells in late S/G2/M phase (in which cyclin E 
exerts effects on mitosis). The thymidine-arrested and peak S/G2/M sam-
ples were then compared on the same blot for cyclin E levels for all trans-
duced and untransduced cell lines. Cyclin E levels for late S/G2/M-phase 
enriched fractions or normalized to levels of the invariant nuclear protein 
Ku86 are plotted below. Cyclin E in cyclin E–transduced KB cells is arbi-
trarily set to 1.0.CYCLIN E OVEREXPRESSION IMPAIRS MITOSIS • KECK ET AL. 373
Roberts, 1993; Resnitzky et al., 1994). A more recent analysis 
revealed that the overexpression of cyclin E specifi  cally im-
pairs the assembly of prereplication complexes upon mitotic 
exit, leading to slow and ineffi  cient DNA replication and most 
likely replicative stress (Ekholm-Reed et al., 2004a). It is easy 
to envisage how replication defects can lead to genomic insta-
bility. In another study in which the cyclin E–targeting F-box 
protein Cdc4 was mutated in cultured cells, impairing cyclin E 
turnover, mitotic aberrations in some cells were observed by 
time-lapse videomicroscopy (Rajagopalan et al., 2004). How-
ever, this study could not distinguish between direct effects on 
mitosis and indirect effects accruing as a result of replicative 
stress, and because SCF
Cdc4 also targets other cellular regula-
tory proteins, the effects could not be defi  nitively attributed to 
cyclin E overexpression.
In this study, we investigate whether cyclin E overexpres-
sion can have a direct impact on the progression through and 
the quality of mitosis. By expressing cyclin E in a manner that 
precludes effects on prereplication complex assembly, we dem-
onstrate that the overexpression of cyclin E expression both de-
lays progression through early phases of mitosis and causes 
mitosis to be executed aberrantly in many cells. Furthermore, 
we demonstrate that these effects are mediated by the direct 
  action of cyclin E–Cdk2 on protein complexes that regulate 
 mitotic  progression.
Results
Deregulating cyclin E expression 
in cultured cells
To study the acute effects of cyclin E overexpression, a recom-
binant adenovirus expressing wild-type (WT) cyclin E from 
the constitutive cytomegalovirus promoter was constructed 
(Ekholm-Reed et al., 2004a). As shown by Western blotting 
(Fig. 1 a), KB cells 24 h after transduction with cyclin E adeno-
virus (Fig. 1 a, ad cyclin E) have increased cyclin E expres-
sion compared with cells transduced with an empty vector 
control adenovirus (Fig. 1 a, ad empty vector [EV] control). 
Although this ectopically expressed cyclin E exhibits some cell 
cycle–dependent regulation, levels are substantially higher 
than WT at all cell cycle phases (Fig. S1, available at http://
www.jcb.org/cgi/content/full/jcb.200703202/DC1). To confi  rm 
that the adenoviral expression of cyclin E resulted in the eleva-
tion of cyclin E–Cdk2 kinase activity with respect to the cell 
cycle, kinase assays were performed on extracts from mitotic 
cells, where cyclin E is not normally expressed. KB cells were 
synchronized using a single thymidine block at the G1/S 
boundary and were released for 8 h into nocodazole (see Fig. 5 a). 
Cyclin E–Cdk2 kinase activity in immunoprecipitates was 
  detectable well above background in mitotically enriched ex-
tracts after transduction with the cyclin E–expressing adenovi-
rus (Fig. 1 b). The level of cyclin E expression throughout the 
cell cycle in the adenovirally transduced cell lines used in the 
current study is equivalent to that characteristic of a subpopu-
lation of breast cancer–derived cell lines that were shown pre-
viously to express high levels of cyclin E (Fig. 1 d; Ekholm-Reed 
et al., 2004a).
Cyclin E overexpression leads to an early 
mitotic delay
Flow cytometry was used to screen for cell cycle abnormalities 
resulting from cyclin E overexpression. Previous studies have 
shown that cells overexpressing cyclin E accumulate in S phase 
(Ohtsubo and Roberts, 1993; Resnitzky et al., 1994; Ekholm-
Reed et al., 2004a). FACS profi  les of asynchronous cyclin E and 
control adenovirus-transduced cells confi  rmed this observation 
but also revealed an increase in G2/M cells (Fig. 1 c; ad cyclin 
E = 17.3% and ad control = 12%).
 The aforementioned fl   ow cytometry experiments re-
vealed an accumulation of cells with 4C DNA content. How-
ever, these experiments were unable to distinguish G2 from 
mitotic populations. Immunostaining cells with an antibody 
reactive with phosphorylated histone H3 (H3-P) produces a 
distinct punctate pattern beginning at centromeres in G2 cells 
and brightly covering entire chromosomes in mitotic cells 
(Hendzel et al., 1997). Fig. 2 a demonstrates the nuclear pat-
tern associated with G2 cells. The onset of histone H3 phos-
phorylation in U2OS cells was confi  rmed to begin in late 
S phase to early G2 by labeling cells with both anti–H3-P and 
anti-BrdU antibodies after a short BrdU pulse (unpublished 
data). Scoring interphase U2OS cells for positive H3-P stain-
ing demonstrated a decreased G2 population in cyclin E adeno-
virus-transduced cells (Fig. 2 a; ad control = 12% and ad 
cyclin E = 6%). This decrease in the fraction of G2 cells indi-
cates that the 4C (G2 + M) accumulation, which was previ-
ously shown by FACS analysis in cells overexpressing cyclin E, 
must be the result of an accumulation of cells in mitosis rather 
than in G2.
To determine whether cyclin E overexpression leads to the 
accumulation of cells at a particular stage of mitosis, the distri-
bution of mitotic phases was scored in asynchronous popula-
tions using immunofl  uorescence microscopy. KB cells were 
transduced with cyclin E or control adenovirus for 24 h, fi  xed, 
and immunostained with anti–H3-P to highlight mitotic cells 
and anti–α-tubulin to label mitotic spindles. Mitotic phases 
were then scored based on the positions of chromosomes and 
the orientation of the mitotic spindle. Six mitotic phases were 
classifi  ed and scored in the analysis: prophase, prometaphase, 
unaligned metaphase, metaphase, anaphase/telophase, and 
  cytokinesis (Fig. 2 b).
Results from such mitotic counts indicate that the over-
expression of cyclin E leads to the accumulation of KB cells in 
prometaphase (Fig. 2 c, ad cyclin E = 31% and ad control = 
24% of the mitotic cells counted) and unaligned metaphase 
(Fig. 2 c, ad cyclin E = 20% and ad control = 13%) compared 
with control cells. The accumulation of cells at early stages of 
mitosis appears to include later stages of prometaphase up until 
the interval of alignment of chromosomes on the metaphase 
plate but not including the point of complete chromosome align-
ment. Consequently, the aligned metaphase population was 
decreased as a percentage of the entire mitotic population (adeno-
virus cyclin E = 13% and adenovirus control = 19%). However, 
once cells overexpressing cyclin E recover from the delay and 
proceed into anaphase, they traverse the later phases of mitosis 
without delay relative to controls.JCB • VOLUME 178 • NUMBER 3 • 2007  374
An early mitotic delay is observed by live 
cell microscopy
For a more complete analysis of mitotic defects caused by the 
overexpression of cyclin E, mitotic division was observed in real 
time. Immortalized mammary epithelial (IME) and U2OS cells 
were transduced with a GFP-tagged histone H2B-expressing 
retrovirus to observe the dynamics of mitotic chromosomes. 
Cells transduced with cyclin E or control adenovirus were fi  lmed 
as they progressed through mitosis.
The recordings of IME and U2OS cells provided direct 
real-time evidence that the overexpression of cyclin E confers 
an early mitotic delay. In addition, they provided insight into 
the dynamics of the prometaphase delay. For live cell record-
ings, unaligned metaphase could not be accurately determined 
as a result of the lack of spindle labeling. Therefore, prometa-
phase was scored as the time from chromosome congression 
toward the midzone until all chromosomes were completely 
aligned at the metaphase plate. Fig. 3 d shows the mean time in 
minutes of prometaphase, metaphase, and anaphase/telophase 
based on recordings of control or cyclin E adenovirus-trans-
duced cells undergoing mitosis. Cyclin E–overexpressing cells 
spent on average almost twofold longer in prometaphase than 
controls (adenovirus cyclin E = 26–29 min and adenovirus 
control = 11–16 min, depending on cell type). In some abnormal 
mitoses characteristic of cyclin E–overexpressing cells, chro-
mosomes oscillated near to the metaphase plate for an ex-
tended period before fi  nally progressing into anaphase with 
  either aligned or unaligned chromosomes. Fig. 3 a illustrates 
mitotic division in a control U2OS cell. Prometaphase is  15 
min, and metaphase begins at 20 min (indicated by the red 
asterisk in Fig. 3 a). Fig. 3 (b and c) shows mitotic divisions in 
cells overexpressing cyclin E with delayed and abnormal pro-
metaphases. In the second   series, a cyclin E–transduced IME 
cell (Fig. 3 b) shows an abnormal prometaphase (>30 min) 
during which chromosomes never progressed to a successful 
metaphase and began anaphase after 38 min despite a failure of 
chromosome alignment. In the third series, a cyclin E–trans-
duced U2OS cell (Fig. 3 c; also shown in Video 1, available at 
http://www.jcb.org/cgi/content/full/jcb.200703202/DC1) de-
layed in prometaphase for almost 40 min, during which chro-
mosomes nearly aligned at the metaphase plate but proceeded 
to oscillate near the plate for a prolonged period until the re-
cording ended. Another demonstration of a cell overexpressing 
cyclin E expression that delays before complete metaphase 
alignment is shown in Video 2.
In addition to the early mitotic delays, mitotic failures 
were observed in which cells overexpressing cyclin E did 
not progress into anaphase but instead began to decondense 
  chromosomes, resulting in a polyploid cell (Video 3, available 
at http://www.jcb.org/cgi/content/full/jcb.200703202/DC1).
This was consistent with our previous observation of an accu-
mulation of polyploid cells in cyclin E–overexpressing popu-
lations (Spruck et al., 1999). Indeed, fl  ow cytometric analysis 
of cyclin E–overexpressing cells indicates a dose-dependent 
Figure 2.  Cells overexpressing cyclin E accumulate in early mitosis rather than in G2 phase. (a) A representative immunoﬂ  uorescence image of U2OS cells 
acquired using deconvolution microscopy showing phosphorylated histone H3 (H3-P) in red and DNA based on DAPI staining in blue. A graph showing 
the percentage of H3-P–positive interphase cells in an asynchronous population when transduced with either cyclin E or EV control retrovirus. Error bars 
represent SEM based on four experiments counting 600 cells. (b) Examples of cells in the six mitotic phases scored in this study for ﬁ  xed cell mitotic counts 
in an asynchronous population: prophase, prometaphase, unaligned metaphase, metaphase, anaphase/telophase, and cytokinesis. DNA was detected 
using DAPI (blue), and microtubules were detected using antitubulin antibodies (green). (c) Graph comparing the percentages of cells in each mitotic phase 
out of the total of mitotic cells counted after transduction with EV control or cyclin E adenovirus. n = 300 mitotic cells counted in ﬁ  ve experiments. Error 
bars represent SEM. Bars (a), 10 μm; (b) 5 μm.CYCLIN E OVEREXPRESSION IMPAIRS MITOSIS • KECK ET AL. 375
failure of mitosis at levels ≥1–2% per cell division (Fig. S2). 
Together, analysis of mitosis in both fi  xed and live cells sug-
gests that a primary consequence of cyclin E overexpression is 
mitotic impairment, which, in extreme cases, can lead to mitotic 
failure and polyploidy.
Cyclin B1 expression is up-regulated, 
and degradation is delayed in metaphase 
as a result of cyclin E overexpression
To investigate the cause of the cyclin E–mediated mitotic delay, 
levels of mitotic regulatory proteins were determined. Single 
cell analysis of cyclin B1 expression was used to compare peak 
levels of cyclin B1 in early mitosis and its degradation in meta-
phase in cells overexpressing cyclin E and controls. KB cells 
were released into mitosis from a single thymidine block. Rep-
resentative images of mitosis in cells transduced with either 
control or cyclin E adenovirus are shown in Fig. 4 a. Cyclin B1 
(Fig. 4 a, green), a centromere-binding protein (Fig. 4 a, red), 
and DNA (Fig. 4 a, blue) were labeled, and cyclin B1 levels 
were measured in early prometaphase cells, unaligned meta-
phase cells, and metaphase cells. Cyclin B1 staining intensities 
of each cell were divided into low, medium, and high categories 
(Fig. 4 b). The overexpression of cyclin E led to elevated levels 
of cyclin B1 in prometaphase and unaligned metaphase. Further-
more, in metaphase, all control cells expressed low levels of cy-
clin B1, as expected as a result of its degradation by the mitotic 
ubiquitin ligase anaphase-promoting complex (APC
Cdc20). 
  However, the degradation of cyclin B1 was delayed in 45% of 
metaphase cells with cyclin E overexpression, which continued 
to express medium and high levels of cyclin B1 (Fig. 4 b, meta-
phase). These results suggest that overexpression of cyclin E can 
delay the normal degradation of cyclin B1. However, cyclin B1 
Figure 3.  Quantitation of cyclin E–mediated mitotic delay by live cell microscopy. Live cell microscopy was performed using IME and U2OS cells express-
ing histone H2B-GFP for the visualization of chromosome dynamics. Differential interference contrast (not depicted) and ﬂ  uorescence (GFP) images were 
recorded once per minute during mitosis using a deconvolution microscope. The time elapsed after recording is indicated at the top left of each frame. 
  Select frames are shown from representative U2OS and IME videos. The red asterisk marks metaphase. (a) A control U2OS cell that begins in prophase, 
progresses into prometaphase, aligns all chromosomes by 20 min (the longest prometaphase recorded in control cells), and initiates chromosome segregation 
after 31 min. (b) An IME cell overexpressing cyclin E that begins in prophase and quickly progresses into prometaphase but never completely aligns all 
chromosomes. After 38 min, chromosome segregation begins despite a failed metaphase. (c) A U2OS cell overexpressing cyclin E that begins in prometa-
phase and continues for 40 min, during which chromosomes migrate toward the metaphase plate but never completely align (also shown in Video 2, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200703202/DC1). (d) Graphs showing the mean time (in minutes) that IME and U2OS cells spend in 
each phase of mitosis. Error bars represent one SD. n = 5 recordings each of IME cells overexpressing cyclin E or controls and 7 recordings each of U20S 
cells overexpressing cyclin E or controls. Bars, 5 μm.JCB • VOLUME 178 • NUMBER 3 • 2007  376
degradation was not completely inhibited, as anaphase cells from 
both control and cyclin E–overexpressing cells contained low 
levels of cyclin B1 (unpublished data).
Cyclin E overexpression causes the 
accumulation of APC substrates up 
to and through mitosis
Next, protein levels of other important APC/C substrates were 
assessed during mitosis. For these experiments, cells were 
transduced with adenovirus and simultaneously arrested in a 
single thymidine block overnight. As adenoviral cyclin E is not 
expressed at substantial levels before 8 h after transduction 
(unpublished data), the majority of nonthymidine-blocked cells 
will have passed through mitosis and early G1 before cyclin E 
accumulation. Therefore, this protocol precludes S-phase de-
fects conferred by cyclin E–mediated interference with prerep-
lication complex assembly in late telophase. In addition, the 
single thymidine block and release protocol ensures approx-
imately equal percentages of cells in G2/M for each time point 
(Fig. 5 a). In KB cells, the peak of mitosis based on microscopic 
observation occurs from 8 to 10 h after release from a thymidine 
block. Western blot analysis of protein expression up to and 
through mitosis in cyclin E–overexpressing and control cells re-
vealed an accumulation of cyclin B1, Cdc20, and securin (Fig. 5, 
b and c). In cells overexpressing cyclin E, mitotic protein levels 
were elevated relative to controls at each time point up to and 
through the peak mitotic samples. These data indicate that de-
fects in mitotic protein expression are not cyclin B specifi  c but 
rather suggest that the APC/C ubiquitin ligase is inhibited under 
conditions of cyclin E overexpression, as all of the proteins ex-
hibiting elevated expression are APC/C substrates targeted for 
ubiquitin-mediated proteolysis.
To determine whether the observed protein accumulations 
were caused by decreased degradation, we examined protein 
stability by carrying out cycloheximide chase experiments un-
der conditions of cyclin E overexpression. Cells transduced 
with cyclin E or control adenovirus and arrested using a single 
thymidine block were then released for 4 h. Cycloheximide was 
added to terminate protein synthesis, and samples were col-
lected, as indicated, for Western blot analysis (Fig. 5, d and e). 
Figure 4.  Cyclin E overexpression leads to the excessive accumulation of cyclin B1 during prometaphase and a delay in cyclin B1 degradation during 
metaphase. (a) Immunoﬂ  uorescence images comparing KB cells transduced with either EV control adenovirus (left) or cyclin E adenovirus (right) in early 
prometaphase, unaligned metaphase, and metaphase. Cyclin B1, a centromere-binding protein, and DNA were stained in ﬁ  xed cells, and images were 
acquired using a deconvolution microscope. (b) Graphs from early prometaphase, unaligned metaphase, or metaphase populations showing the percent-
age of EV control and cells overexpressing cyclin E with low, medium, or high cyclin B1 levels. ImageJ was used to measure mean pixel intensities of cyclin 
B1 in cells from 8-bit grayscale images. The area of each cell was used to account for variations in cell size. Cyclin B levels were arbitrarily divided into 
low, medium, and high groupings. X axis, cyclin B1 level; y axis, percentage of the total number of cells. n = 10 control and cyclin E–overexpressing cells 
each per mitotic phase. Error bars correspond to the variance based on two experiments.CYCLIN E OVEREXPRESSION IMPAIRS MITOSIS • KECK ET AL. 377
As can be seen, cyclin B1, securin, and Cdc20 were degraded 
much more rapidly in control cells compared with cells over-
expressing cyclin E, suggesting that the cyclin E–mediated accumu-
lation of key mitotic regulatory proteins occurs by decreasing 
their rate of ubiquitin-mediated proteolysis.
Overexpressed cyclin E–Cdk2 binds 
and phosphorylates Cdh1
The data presented up to this point suggest that elevated cyclin E–
Cdk2 inhibits the APC/C. APC/C activity requires one of two 
activating regulatory subunits, Cdc20 or Cdh1 (Visintin et al., 
1997; Kramer et al., 2000). Cdc20 is thought to activate the APC/C 
during mitosis, whereas Cdh1 is the activating subunit from 
mitotic exit to the G1/S boundary (Fang et al., 1998; Jaspersen 
et al., 1999; Lukas et al., 1999; Blanco et al., 2000; Kramer et al., 
2000; Sorensen et al., 2000). Because Cdc20 itself was found to 
accumulate in response to cyclin E overexpression, it was un-
likely to be the relevant target of cyclin E–Cdk2. On the other 
hand, whereas Cdh1 is inactivated by phosphorylation, it is 
thought to already be inactive during early mitosis as a result 
of the phosphorylation by cyclin A–Cdk2 (Lukas et al., 1999; 
Sorensen et al., 2001). However, recent studies have suggested 
that Cdh1 does contribute to early mitotic APC/C activation 
(Jeganathan et al., 2005, 2006), raising the possibility that it is the 
target of cyclin E overexpression. Furthermore, although under 
normal circumstances, it was shown that cyclin E–Cdk2 does not 
contribute substantially to Cdh1 phosphorylation and inactiva-
tion (Brandeis and Hunt, 1996; Lukas et al., 1999; Sorensen 
et al., 2001), overexpressed cyclin E might be able to interact 
with and phosphorylate Cdh1.
Figure 5.  Cyclin E overexpression causes the accumulation of APC/C substrates up to and through mitosis as a result of increased protein stability. (a) Rep-
resentative FACS proﬁ  les (propidium iodide staining) from EV control and cyclin E adenovirus–transduced KB cells collected at speciﬁ  c times after release 
from a thymidine block. (b) Representative Western blot analyses showing the elevated expression of APC/C substrates cyclin B, Cdc20, and securin in cy-
clin E–overexpressing cells compared with control cells. β-actin is used as a loading control in both experiments. Dividing lines represent splicing of an 
empty lane from the blot. (c) Band densities from panel b quantiﬁ  ed and normalized to actin. (d) Western blot analysis of a cycloheximide (CHX) chase ex-
periment showing the stabilization of APC/C substrates under conditions of cyclin E overexpression. Degradation of cyclin B, securin, and Cdc20 was as-
sayed after thymidine synchronization and a 4-h release into late S/G2 phase. Cycloheximide was added at 0 min, and samples were collected at 0 min, 
15 min, 30 min, 1.5 h, and 2.5 h after cycloheximide addition. (e) Quantitation of the cycloheximide chase experiment in panel d. Band intensities were 
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We fi rst determined whether cyclin E–Cdk2 could bind 
  directly to Cdh1 because protein kinases often form stable com-
plexes with substrates. Cyclin A binding to Cdh1 has previously 
been described and was used as a positive control (Lukas et al., 
1999; Sorensen et al., 2001). Three expression plasmids coding 
for N-terminally myc-tagged WT or mutants Cdh1
RVL-AAA and 
Cdh1
4A were used to characterize the binding of cyclin E and 
cyclin A to Cdh1 (Sorensen et al., 2001). Cdh1
RVL-AAA is mutated 
in the WD-40 repeat domain at the RVL motif, which has been 
shown to be necessary for cyclin A binding, and Cdh1
4A is 
mutated at four phosphorylation sites shown to be targeted by   
cyclin A–Cdk2 that are essential for Cdh1 inhibition. Expression 
plasmids for cyclin E or cyclin A were cotransfected with ex-
pression plasmids encoding Cdh1
WT, Cdh1
AAA, Cdh1
4A, or an 
empty vector into 293T cells. Cdh1 was immunoprecipitated 
from cell lysates using anti-myc antibody. The immunoprecipi-
tation data show that exogenous cyclin E binds effi  ciently to 
Cdh1
WT as does the positive control, cyclin A (Fig. 6 a). In addi-
tion, weak binding is detectable between exogenous cyclin A and 
both Cdh1 mutants. Exogenous cyclin E also bound both WT 
and, to a lesser degree, both mutant Cdh1 mutants. However, no 
binding was observed at endogenous levels of cyclin E (shown 
as a band with lower mobility than exogenous cyclin E), which 
is consistent with previous results (Sorensen et al., 2001).
To determine whether Cdh1 is a substrate of cyclin E–
Cdk2, in vitro phosphorylation assays were performed. GST-
Cdh1 (Sorensen et al., 2001) and GST alone were purifi  ed from 
Escherichia coli. In vitro kinase assays were performed using 
Figure 6.  Cyclin E and cyclin A can bind and phosphorylate the APC-activating subunit Cdh1, leading to reduced association with the APC. (a) Immuno-
precipitation assay using the empty vector or one of three myc-tagged Cdh1 constructs: WT (wild-type), AAA (an RxL motif cyclin-binding mutant), or 4A 
(a phosphorylation site mutant). Cdh1 and cyclin E or cyclin A expression plasmids were transiently transfected into 293T cells. Cell lysates were immuno-
precipitated with anti-myc antibody, separated by SDS-PAGE, and detected by Western blotting. Both exogenous and endogenous cyclin A are detected us-
ing anti–cyclin A. Endogenous and exogenous cyclin E are detected using an anti–cyclin E antibody (endogenous cyclin E is observed migrating more 
slowly than exogenous; both are marked with asterisks). (b) In vitro kinase assay with GST-Cdh1 puriﬁ  ed from E. coli. Puriﬁ  ed cyclin E–Cdk2, cyclin 
A–Cdk2, or buffer were incubated with γ-[
32P]ATP and either histone H1 (ﬁ  rst three lanes), GST-Cdh1 (middle three lanes), or GST alone (last three lanes). 
(c) Cdh
WT exhibits reduced mobility upon the cotransfection of cyclin E or cyclin A as a result of increased phosphorylation. Transfection of 293T cells was 
performed as described in panel a. Cell lysates were incubated with λ-phosphatase in the presence or absence of phosphatase inhibitors as indicated. 
  Lysates were separated by SDS-PAGE and immunoblotted using anti-Cdh1 antibody for detection. β-Actin serves as a loading control. (d) Western blot show-
ing the phosphorylation of endogenous Cdh1 in KB cells transduced with adenoviral cyclin E. Cells were transduced with EV control or cyclin E adenovirus, 
which was arrested using a single thymidine block, and released. Samples were collected as cells progressed into and through mitosis and were analyzed 
for Cdh1 migration by SDS-PAGE followed by Western blotting and detection using anti-Cdh1 antibody. Slower migrating band represents hyperphosphor-
ylated Cdh1 based on the experiment shown in panel c. Lines indicate where irrelevant lanes were spliced out. (e) Cdc27 immunoprecipitation quantitating 
APC-associated Cdh1 in synchronized S/G2 cells. Cells were transfected with a plasmid expressing myc-tagged Cdh1 and were transduced with cyclin 
E–expressing or control adenovirus. 4 h after release from a thymidine block, lysates were prepared and immunoprecipitated using Cdc27 antibody. 
  Lysates and immunoprecipitates were separated by SDS-PAGE followed by Western blotting using Cdc27 and Cdh1 antibody. The graph represents the Cdh1 
band density normalized to the Cdc27 band density, where the control ratio is arbitrarily set to 1.0.CYCLIN E OVEREXPRESSION IMPAIRS MITOSIS • KECK ET AL. 379
cyclin E– and cyclin A–Cdk2 purifi  ed from baculovirus-trans-
duced insect cells on histone H1, GST, and GST-Cdh1 as sub-
strates (Fig. 6 b). Robust phosphorylation of histone H1 by 
cyclin E– and cyclin A–Cdk2 confi  rmed that both kinase com-
plexes were active. GST alone ( 28 kD) was not phosphorylated 
by either cyclin–Cdk2 complex. However, purifi  ed GST-Cdh1 
(75 kD) as well as several degradation products were phosphor-
ylated by both cyclin E– and cyclin A–Cdk2.
Phosphorylation of Cdh1 was also confi  rmed in cell cul-
ture. In Fig. 6 a, reduced mobility was shown for Cdh1
WT and 
Cdh1
RVL-AAA when coexpressed with either cyclin E or cyclin A. 
To ensure that the reduced mobility was a result of the 
phosphorylation of Cdh1, parallel samples using Cdh1
WT were 
treated with λ-phosphatase to dephosphorylate Cdh1 before 
analysis (Fig. 6 c). Cdh1 exhibited reduced mobility upon the 
cotransfection of either cyclin E or cyclin A, which was reversed 
with phosphatase treatment, but not when phosphatase inhibi-
tors were present, indicating that ectopically expressed Cdh1 
can be phosphorylated by either cyclin E– or cyclin A–Cdk2.
Next, we assessed the ability of cyclin E–Cdk2 to phos-
phorylate endogenous Cdh1 under conditions in which the 
cyclin E–mediated accumulation of mitotic APC/C substrates 
was observed (as in Fig. 5). Samples were collected up to and 
through mitosis after a thymidine block and release (Fig. 6 d). 
Overexpression of cyclin E reduced the mobility of endogenous 
Cdh1 (Fig. 6 d), which is consistent with cyclin E–Cdk2 con-
tributing substantially to the phosphorylation and inactivation 
of Cdh1 under these conditions. To determine whether the 
phosphorylation of Cdh1 by cyclin E–Cdk2 under these condi-
tions affected the association of Cdh1 with APC, cells were 
transfected with a plasmid expressing myc-Cdh1 and were 
transduced with cyclin E–expressing or control adenovirus. 
APC immunoprecipitates (using Cdc27 antibody) were then 
prepared 4h after release from a thymidine block. Cdh1 associa-
tion with the APC was reduced to  60% of control values as a 
consequence of cyclin E overexpression (Fig. 6 e).
Cyclin E–Cdk2 inhibits the APC
Cdh1-
dependent ubiquitylation of cyclin B1 
in vitro
To assess the effects of cyclin E–Cdk2 on the activity of 
APC
Cdh1 directly, in vitro ubiquitylation assays were performed 
(Fig. 7). Cdh1 was phosphorylated in vitro before addition to 
the ubiquitylation reaction. APC
Cdh1 activity was determined by 
the conversion of unmodifi  ed cyclin B1 to multiubiquitylated 
cyclin B1 derivatives.
Cyclin B1 was effi  ciently ubiquitylated when Cdh1 was 
added to the reaction in the absence of cyclin E–Cdk2 (Fig. 7 a). 
Upon the addition of purifi  ed cyclin E–Cdk2, the ubiquity-
lation of cyclin B1 was dramatically reduced, which is consis-
tent with the phosphorylation-dependent inhibition of Cdh1 
(Fig. 7 a; and quantifi  ed in b). The addition of purvalanol, a Cdk 
inhibitor, partially reversed cyclin E–mediated inhibition. These 
data suggest that cyclin E–Cdk2 inhibits Cdh1 via phosphoryl-
ation. Furthermore, a phosphorylation site mutant of Cdh1, 
where all possible Cdk sites were mutated to alanines, was 
Figure 7.  Cyclin E–Cdk2 inhibits APC
Cdh1 ubiquitin ligase activity in vitro through a kinase-dependent mechanism. (a) In vitro ubiquitylation was used to as-
sess inhibition of the APC
Cdh1 by cyclin E–Cdk2. Autoradiography was used to visualize both the unmodiﬁ  ed and ubiquitin-conjugated 
35S-labeled N-terminal 
fragment of cyclin B1. The addition of cyclin E–Cdk2 and/or the Cdk inhibitor purvalanol A to the various reactions is indicated. Reactions were performed 
in parallel with WT Cdh1 (Cdh1-WT) and a Cdk phosphorylation site mutant (Cdh1-Ala). (b) Quantitation of unmodiﬁ  ed cyclin B1 remaining in the reactions 
shown in panel a. Error bars represent the variance of the mean from two independent experiments.JCB • VOLUME 178 • NUMBER 3 • 2007  380
completely   resistant to cyclin E–Cdk2-mediated inhibition 
(Fig. 7 a; and quantifi  ed in b). These data confi  rm that cyclin E–
Cdk2 can   inactivate APC
Cdh1 through the inhibitory phosphoryl-
ation of Cdh1.
Reduction of Cdh1 levels results in mitotic 
protein accumulation and mitotic delay 
similar to the overexpression of cyclin E
If cyclin E–Cdk2 inhibits APC
Cdh1 in vivo, reducing cellular lev-
els of Cdh1 should mimic the phenotype associated with the 
overexpression of cyclin E. Using Cdh1-specifi  c siRNA, the 
effects of Cdh1 reduction were compared with those associated 
with cyclin E overexpression. A strong knockdown of Cdh1 
protein (using 20 nM of Cdh1-specifi  c siRNA) inhibited cell 
proliferation, which had previously been reported (Sorensen 
et al., 2001; Gimenez-Abian et al., 2005b). To only partially ablate 
Cdh1, the time of incubation and the concentration of Cdh1-
specifi  c siRNA were reduced. The accumulation of cyclin B1, 
securin, and Cdc20 in cells targeted by Cdh1-specifi  c siRNA 
was compared with that in cells transduced with cyclin E or 
control adenovirus (Fig. 8 a). A comparable up-regulation of 
cyclin B1, securin, and Cdc20 protein occurs as a result of both 
Cdh1 reduction and cyclin E overexpression.
We next determined the effects of reducing Cdh1 on mi-
totic progression. Fixed cells were scored as previously dis-
cussed (see section Cyclin E overexpression leads to an early 
mitotic delay) in asynchronous populations after the trans-
duction of EV control or cyclin E adenovirus for 24 h and 
incubation with Cdh1- or GFP-specifi  c siRNA for an additional 
24 h (Fig. 8 b). As shown previously, cyclin E overexpression 
caused an accumulation in early mitosis before metaphase. 
This same trend, but with a more pronounced effect, was ob-
served in cells partially silenced for Cdh1 (Fig. 8 b). These 
data confi  rm that Cdh1 has a role in the regulation of progres-
sion through early mitosis and that cyclin E–mediated in-
hibition of Cdh1 could, in principle, account for the impairment 
of early mitotic events.
Reducing the levels of APC
Cdh1 
substrates cyclin B1 and securin in cells 
overexpressing cyclin E allows progression 
through mitosis without delay
Based on the aforementioned data, the direct reduction of Cdh1 
or overexpression of cyclin E leads to the accumulation of 
mitotic APC/C substrates and delay in progression through 
early mitosis. However, whether the mitotic delay is caused by 
the accumulation of APC/C substrates and, if so, which APC/C 
substrates contribute to the mitotic delay remained to be deter-
mined. Based on our observations, it appeared that most chro-
mosomes become bioriented but delay in aligning at the metaphase 
plate and progressing into anaphase. This phenotype is consistent 
with a defect in sister chromatid separation possibly caused by 
elevated levels of cyclin B1 and securin as cells progress into and 
through mitosis. Degradation of securin and cyclin B1 is needed 
to activate separase and thereby promote the cleavage of cohesin 
(Gorr et al., 2005; Ji et al., 2005), which is required for separation 
of the sister chromatids at anaphase, allowing the poleward mi-
gration of chromosomes (Uhlmann et al., 1999, 2000; Hauf et al., 
2001; Gimenez-Abian et al., 2005a). Therefore, we tested whether 
slightly reducing securin and cyclin B1 expression in cells over-
expressing cyclin E could override the cyclin E–induced delay of 
early mitosis.
Cells were transduced with EV control or cyclin E adeno-
virus for 24 h and transfected with low concentrations of siRNA 
(10 pM) targeting securin and/or cyclin B1 or GFP for an addi-
tional 24 h. Expression of cyclin B1 and securin in cells re-
leased into mitosis from a thymidine block was compared by 
Western blot analysis (Fig. 9 a). Cells transduced with cyclin E 
adenovirus and transfected with cyclin B1– and securin-specifi  c 
siRNA resulted in levels of cyclin B1 and securin comparable 
with those found in control cells, whereas cells transfected with 
control GFP-specifi  c siRNA continued to exhibit elevated levels 
of cyclin B1 and securin. As expected, Cdc20 levels were not 
affected by siRNA targeting cyclin B1 and securin.
Mitotic progression was assessed in cells with reduced 
levels of securin and cyclin B1, securin alone, or cyclin B1 
alone mediated by siRNA transfection (Fig. 9 b). Reducing both 
cyclin B1 and securin eliminated the delays in prometaphase 
and unaligned metaphase along with the resulting decrease in 
the percentage of metaphase cells mediated by cyclin E over-
expression. However, reducing securin or cyclin B1 alone did not 
completely eliminate the prometaphase or unaligned metaphase 
delay associated with cyclin E overexpression. Therefore, the 
Figure 8.  Reducing Cdh1 by RNAi mimics cyclin E overexpression, result-
ing in mitotic protein accumulation and early mitotic delay. (a) Western 
blot comparing the accumulation of cyclin B1, securin, and Cdc20 in cells 
subjected to partial silencing of Cdh1 using siRNA or overexpressing cyclin E. 
Asynchronous populations were collected and analyzed by immuno-
blotting. Dividing lines indicate where the gel was spliced to remove ir-
relevant lanes. (b) Mitotic counts of cells subjected to Cdh1-speciﬁ  c RNAi. 
Cells were transfected with Cdh1-speciﬁ  c siRNA or transduced with EV 
control or cyclin E adenovirus followed by transfection with GFP-speciﬁ  c 
siRNA. n = 300 cells per sample. Error bars correspond to the SEM based 
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depl etion of securin or cyclin B1 alone is not suffi  cient to allevi-
ate the mitotic inhibitory effects of cyclin E overexpression and 
suggests that stabilization of both proteins contributes to cyclin E–
mediated mitotic delay.
Discussion
Inhibition of APC
Cdh1 affects progression 
through early stages of mitosis
Although Cdh1 can activate both mitotic and interphase APC/C, 
models of cell cycle regulation have proposed that the ubiqui-
tin ligase ACP
Cdh1 is maintained in an inactive state from the 
G1/S boundary until mitotic exit as a result of phosphorylation 
by Cdks active during this interval (Zachariae et al., 1998; 
Jaspersen et al., 1999; Lukas et al., 1999; Blanco et al., 2000; 
Kramer et al., 2000; Sorensen et al., 2001). Although there is 
evidence that cyclin E–Cdk2 is primarily responsible for the 
accumulation of G2/M cyclins and Cdh1 phosphorylation in 
Drosophila melanogaster (Knoblich et al., 1994; Sigrist and 
Lehner, 1997), in mammalian cells, it was shown that cyclin A–
Cdk2 specifi  cally phosphorylates Cdh1 on a number sites 
and that this phosphorylation prevents association with the 
APC/C core (Sigrist and Lehner, 1997; Lukas et al., 1999; 
Sorensen et al., 2001). Because cyclin A–Cdk2 becomes active 
at the G1/S transition and persists until early mitosis, it has 
been assumed that Cdh1 does not contribute to APC/C ubiqui-
tin ligase activity during this interval and that only an alterna-
tive APC/C cofactor, Cdc20, carries out mitotic functions. 
However, a recent study suggests that APC
Cdh1 does have a 
role in the ubiquitylation of securin during early mitosis in 
that mice carrying mutations that misregulate Cdh1 nuclear 
transport exhibit mitotic defects (Jeganathan et al., 2005). 
Consistent with this fi  nding, in the present study, we show that 
APC
Cdh1 activity must contribute to the regulation of mitotic 
proteins up to and through early mitosis. Specifi  cally, the par-
tial silencing of Cdh1 by RNAi led to a hyperaccumulation 
of APC substrates and impaired progression through early 
phases of mitosis. Therefore, APC
Cdh1 must retain residual 
activity before mitosis even in the presence of cyclin A–Cdk2. 
This conclusion, along with the observed ability of cyclin E–
Cdk2 to phosphorylate Cdh1 in vivo and inhibit APC
Cdh1 
in vitro, is consistent with a model in which cyclin E–mediated 
effects on mitosis are caused by the inhibition of residual 
APC
Cdh1 activity.
This proposal is seemingly at odds with previous re-
ports that cyclin E–Cdk2 does not bind to Cdh1 or contribute to 
its phosphorylation in mammalian cells (Lukas et al., 1999; 
  Sorensen et al., 2001). Indeed, we could not detect an associa-
tion between endogenous cyclin E and Cdh1. However, when 
cyclin E was overexpressed by transfection, the association of 
cyclin E with Cdh1 and the cyclin E–mediated hyperphosphor-
ylation of Cdh1 were readily detectable. These data suggest that 
when normally expressed at the G1/S boundary, cyclin E is unlikely 
to have a major impact on Cdh1 regulation. However, over-
expressed cyclin E, either in the experimental contexts reported 
here or in the course of tumorigenesis, can infl  uence Cdh1 
activity in a manner that has functional consequences. Whether 
the temporal deregulation of cyclin E expression, simply the 
deregulation of cyclin E levels, or both allows cyclin E to have 
an impact on Cdh1 activity remains to be determined.
Figure 9.  Reducing the accumulation of 
APC
Cdh1 substrates cyclin B1 and securin in 
cells overexpressing cyclin E restores normal 
progression through mitosis. (a) Elevation of 
mitotic regulatory proteins cyclin B1 and securin 
in mitotically enriched KB cells overexpressing 
cyclin E can be reversed using low concentra-
tions of sequence-speciﬁ   c siRNA. Cells were 
subjected to a single thymidine block and har-
vested 8 h after release. Cyclin B1 and securin 
levels were reduced by transfection with corre-
sponding siRNAs. Band densities normalized 
to actin are shown beside the Western blot. 
(b) Mitotic progression in cells overexpress-
ing cyclin E is no longer delayed if the hyper-
accumulation of both cyclin B1 and securin 
are prevented by sequence-speciﬁ  c RNAi. Cells 
were transduced with cyclin E or EV control 
adenovirus followed by transfection with se-
quence-speciﬁ  c siRNA as indicated and were 
processed for immunoﬂ  uorescence as described 
in Materials and methods. Mitotic counts of 
ﬁ  xed KB cells were performed as described in 
Materials and methods. The graph compares 
percentages of prometaphase, unaligned meta-
phase, and metaphase out of the total mitotic 
population counted from cells treated with GFP 
siRNA, individual targeting of securin or cyclin 
B1, and simultaneous targeting of cyclin B1 and 
securin. Error bars represent the SEM based on 
three experiments. Asterisks indicate compari-
sons in which the difference reaches a ≥90% 
conﬁ  dence level (*, P ≤ 0.1).JCB • VOLUME 178 • NUMBER 3 • 2007  382
APC
Cdh1 targets relevant to the 
cyclin E–mediated impairment of mitosis
Overexpression of cyclin E causes cells to delay in mitosis be-
fore anaphase. This phenotype could be explained by a cyclin E–
mediated failure to activate the mitotic protease separase. 
Indeed, it has been reported that one defect caused by the 
RNAi-mediated depletion of separase is a prometaphase delay 
similar to that reported here in the context of cyclin E overex-
pression (Gimenez-Abian et al., 2005a). In addition, the deple-
tion of separase induces polyploidy (Waizenegger et al., 2002). 
Separase specifi  cally cleaves the cohesin subunit Scc1, result-
ing in a loss of centromeric sister chromatid cohesion in mam-
malian cells, potentiating anaphase (Uhlmann et al., 1999, 2000; 
Waizenegger et al., 2000; Hauf et al., 2001). The primary mode 
of separase regulation is through the binding of the separase 
  inhibitor securin (Cohen-Fix et al., 1996; Zou et al., 1999). 
  Securin ubiquitylation by the APC/C targeting it for protea-
somal degradation during the early phases of mitosis is thought 
to constitute the principal mitotic regulatory role of the APC/C. 
However, the role of securin ubiquitylation during early mitosis 
has been attributed to the APC/C cofactor Cdc20 rather than 
Cdh1, as the latter cofactor has been assumed to be inactive dur-
ing this interval (Visintin et al., 1997; Zachariae et al., 1998; 
Jaspersen et al., 1999; Salah and Nasmyth, 2000). Indeed, in 
yeast, the inactivation of Cdc20 leads to metaphase arrest, 
whereas the inactivation of Cdh1 has no obvious effects on early 
stages of mitosis (Sigrist et al., 1995; Cohen-Fix et al., 1996; 
Kramer et al., 2000).
Nevertheless, we show that in mammalian cells, partial si-
lencing of Cdh1 by RNAi leads to the accumulation of securin 
and an early mitotic delay, and it has been reported that mam-
malian APC
Cdh1 shares the capacity to target securin with 
APC
Cdc20 (Zur and Brandeis, 2001). Therefore, it was reason-
able to consider securin as the relevant anaphase inhibitory tar-
get stabilized by the cyclin E–mediated inhibition of Cdh1. 
However, when securin expression was adjusted by partial RNAi-
mediated silencing so that cyclin E overexpression restored se-
curin to normal levels, early mitotic delay was not abrogated. 
Recent studies have suggested that cyclin B1–Cdk1 also inhibits 
separase, raising the possibility that the abnormal accumulation 
of cyclin B1 during early mitosis may also contribute to cyclin E–
mediated mitotic delay (Gorr et al., 2005; Ji et al., 2005). 
However, as with securin, RNAi- mediated restoration of cyclin 
B1 levels alone was not suffi  cient to completely abrogate mitotic 
delay. Only when the simultaneous restoration of both securin 
and cyclin B1 was performed were the mitotic effects of cyclin E 
overexpression neutralized. The contribution of two distinct and 
possibly synergistic mitotic inhibitors explains why seemingly 
modest elevation of levels of these proteins has a profound effect 
on progression through mitosis.
The nature of cyclin E–mediated 
mitotic delay
Based on observations made from fi  xed cells, the overexpres-
sion of cyclin E causes an accumulation of cells either in a pro-
metaphase-like state or a state in which chromosomes are almost 
but not completely aligned on the metaphase plate. However, 
this categorization was a formalism. Because these are static 
observations, we cannot describe the sequence of events in real 
time that led to the accumulation of these cell types. It is possi-
ble that both of these phenotypes refl  ect the same population re-
sulting from an inability to lose sister chromatid cohesion. 
Normally, centromeric cohesion is lost when bioriented chro-
mosomes are aligned at metaphase. However, the inability to 
lose cohesion in a timely manner may promote an unusually 
dynamic situation in which chromosomes under tension cycli-
cally move toward and away from the metaphase plate, poten-
tially accounting for both of the observed populations that 
accumulate as a result of cyclin E overexpression. Indeed, in 
time-lapse series of such cells, chromosomes appeared to be 
unusually dynamic, undergoing substantial oscillatory move-
ments for long periods of time. However, because spindles and 
centromeres were not visible under these circumstances, it was 
not possible to evaluate the attachment or tension status of chro-
mosomes. The observation that mitotic chromosomes in cells 
overexpressing cyclin E appear hypercondensed (unpublished 
data) is also consistent with a prolonged prometaphase or meta-
phase caused by the inability to lose cohesion in a timely fash-
ion (Waizenegger et al., 2002; Gimenez-Abian et al., 2005a).
Materials and methods
Cell culture and modeling cyclin E overexpression
Immortalized human ﬁ  broblasts and IME cells, two cell lines immortalized 
by stable transduction with a pBABEpuro retrovirus expressing the human 
telomerase reverse transcriptase gene (gift from J. Shay, The University of 
Texas Southwestern Medical Center, Dallas, TX), were used in initial 
experiments for chromosome painting, ﬂ  ow cytometry, and live cell mi-
croscopy analysis. U2OS cells, an osteosarcoma cell line, were used for 
immunoﬂ  uorescence and live cell microscopy experiments. KB cells, a hu-
man nasopharyngeal epidermoid carcinoma, and breast cancer–derived 
cell lines MDA-MB-157, -436, and -468 (American Type Culture Collec-
tion) were used for immunoﬂ  uorescence microscopy and biochemical 
experiments. IME cells were cultured in MCDB media (Invitrogen) and 
supplemented with 1% FCS, holotransferrin, EGF, bovine pituitary extract, 
insulin, L-glutamine, 100 U/ml penicillin, and 1.0 mg/ml streptomycin. All 
other cells were grown in DME (Invitrogen) supplemented with 10% FCS 
or 20% normal calf serum and 100 U/ml penicillin, 1.0 mg/ml streptomy-
cin, and L-glutamine.
Recombinant retroviruses expressing a hyperstable form of cyclin E 
(T380A) or a control empty vector were prepared using the 293T-derived 
packaging cell line Phoenix-Ampho and the pBABE retroviral plasmid vec-
tor (Morgenstern and Land, 1990) containing a hygromycin resistance 
marker for the selection of long-term stable expression mediated by the 
constitutive retrovirus long terminal repeat promoter. Viral preparation 
steps are listed as follows: Phoenix-Ampho cells were transfected overnight 
by calcium phosphate precipitation; 24 h after transfection, medium was 
changed; 48 h after transfection, virus-containing medium was harvested; 
and 0.2 μm was ﬁ  ltered and frozen in aliquots for future use. Viral infec-
tion steps are listed as follows: frozen viral aliquots were thawed at RT, and 
retrovirus was added to cells with an equal amount of medium (10% FCS) 
for 24 h, after which fresh media was added. Cells carrying the retrovirus 
construct were selected after 48 h using 200 ng/ml hygromycin.
Recombinant adenovirus expressing WT cyclin E or a control empty 
vector under the constitutive cytomegalovirus promoter were puriﬁ  ed by 
CsCl ultracentrifugation. Cells were transduced with  1,000 virus parti-
cles/cell (comparable with the levels used in Ekholm-Reed et al., 2004a) in 
a low volume of medium with 0% serum for 2 h, and then additional 
medium plus 10% FCS was added for 24 h. Cyclin E expression in IME, 
U2OS, and KB cells was assayed by Western blotting and immunoﬂ  uores-
cence microscopy.
The histone H2B-GFP retrovirus was constructed from an H2B-GFP 
expression plasmid (BOS H2BGFP-N1; a gift from K. Sullivan, National 
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cut and ligated into a pBabe backbone containing a neomycin resistance 
marker for selection. Viral preparation and transduction were performed 
as for the cyclin E retrovirus.
SDS-PAGE electrophoresis and Western blotting analysis
Lysates were extracted in cold lysis buffer (50 mM Tris, 150 mM NaCL, 
1 mM EDTA, 1% Triton X-100 detergent, and phosphatase/protease inhibi-
tors), sonicated, and cleared for 10 min at 10,000 g at 4°C, and protein 
concentrations were determined using a Bradford solution (Bio-Rad Labora-
tories) read at 595 nM. For Western blotting analysis, samples were sepa-
rated by SDS-PAGE and transferred onto Immobilon P membranes (Millipore). 
Filters were then blocked for 1 h at room temperature in blocking buffer 
(5% nonfat milk in 1× TBS plus 0.1% Triton X-100 [TBS-T = 10 mM Tris, 
500 mM NaCl, and 0.1% Triton X-100, pH 8]). Primary antibody was added 
in blocking buffer overnight at 4°C. HRP-conjugated secondary antibodies 
(1:5,000) diluted in blocking buffer were incubated with the membrane for 
1 h at RT. Primary antibodies used were anti–cyclin E monoclonal antibody 
(HE12; Santa Cruz Biotechnology, Inc.) at 1:1,000, anti–cyclin B1 mono-
clonal antibody (BD Biosciences) at 1:1,000, anti–cyclin A polyclonal anti-
body (Santa Cruz Biotechnology, Inc.) at 1:1,000, anti-Cdc20 polyclonal 
antibody (Abcam) at 1:300, anti-Cdh1 monoclonal antibody (Calbiochem) 
at 1:200, antisecurin monoclonal antibody (Abcam) at 1:200, anti-myc 
(9E10; Sigma-Aldrich), and anti–β-actin polyclonal antibody (Sigma-Aldrich) 
at 1:10,000.
Immunoﬂ  uorescence
Cells were plated onto acid-washed glass coverslips. Cells were ﬁ  xed for 
10 min at room temperature in 2% PFA in 1× PBS and for 10 min in metha-
nol at −20°C or in cold methanol alone for 10 min (for the detection of cy-
clin E). Cells were then permeabilized with PBS-TX (1× PBS + 0.1% Triton 
X-100) for 15 min followed by incubation in blocking solution (PBS-TX + 
1% BSA) at 37°C for 30 min. Coverslips were incubated with primary anti-
bodies diluted in blocking solution overnight at 4°C in a humidity chamber. 
Secondary antibodies were used at a dilution of 1:250 (Cy2, Rhodamine 
red-X, or Cy5; Jackson ImmunoResearch Laboratories) and incubated for 1 h 
at RT. Cells were washed and dehydrated with sequential washes of 70, 
90, and 100% ethanol. Coverslips were mounted using SloFade with DAPI 
(Invitrogen). Primary antibodies used were anti–cyclin E monoclonal anti-
body (HE12) at 1:1,000, anti–cyclin B1 monoclonal antibody (BD Bio-
sciences) at 1:1,000, antiphosphorylated histone H3 (mitotic marker; Upstate 
Biotechnology) at 1:400, anti–α-tubulin (Dm1a; Sigma-Aldrich) at 1:1,000, 
anti-Sm human autosera (centromere-binding protein; gift from K. Sullivan) 
at 1:100, and sheep polyclonal anti-BrdU (Research Diagnostics, Inc.).
Deconvolution microscopy
Images were collected at intervals of 0.3 μm in the z direction on a wide-
ﬁ  eld optical sectioning microscope system (DeltaVision; Applied Precision) 
based on an epiﬂ   uorescence microscope (IX70; Olympus). A 60× or 
100× 1.35 NA neoﬂ  uor oil immersion lens (Olympus) was used. Images 
were processed using a constrained iterative deconvolution algorithm. All 
images shown are projections of multiple focal planes, which were created 
using SoftWoRx analysis software (Applied Precision) and contain informa-
tion from 3D image stacks.
Live cell microscopy
IME or U2OS cells expressing H2B-GFP were grown directly on glass cover-
slips. Cells were maintained during imaging in phenol red–free DME 
plus 10 mM Hepes, pH 7.5, buffer in a closed chamber system (Bioptechs) 
on a heated stage at 37°C. 5 3-μm sections of differential interference 
contrast and FITC ﬂ  uorescence images were acquired at 1-min intervals 
with a cooled CCD camera mounted on a deconvolution microscope system 
(DeltaVision; Applied Precision).
Flow cytometry
For ﬂ  ow cytometry, cells were collected by trypsinization, washed with 1× 
PBS, and ﬁ  xed with 70% ethanol (added dropwise with agitation) over-
night at −20°C. Samples were then washed and resuspended in 1 ml PBS-
TX plus 10 μg/ml RNase solution and 2 μg/ml propidium iodide overnight 
at 4°C. For BrdU staining, cells were pulsed with 10 μM BrdU for 20 min 
before collection. Cells were treated with 1 ml HCL + 0.5% Triton X-100 
for 30 min at RT to denature DNA. The cell suspension was neutralized 
with 2 ml of 0.1 M Borax. Cells were washed with 1× PBS and re-
suspended in 50 μl of 1× PBS/1% BSA/0.5% Tween 20 and incubated in 
2.5 μg/ml FITC-conjugated anti-BrdU antibody for 1 h at RT. Cells were then 
washed and incubated with propidium iodide overnight. Before analysis, 
cells were ﬁ   ltered through a 74-μm mesh (Small Parts) to remove cell 
clumps before detection on a ﬂ   ow cytometer (FACSCalibur II; Becton 
Dickinson). For each cell line, 30,000 cells were counted per sample. Data 
were analyzed using CellQuest (Becton Dickinson). All cell lines were ana-
lyzed using the same user-deﬁ  ned Gates and Regions to obtain percent-
ages of cells with a G1, S, or G2/M DNA content.
Thymidine block release protocol for synchronous release into mitosis
KB cells were transduced with EV control or cyclin E adenovirus for 2 h and 
incubated in medium with 1.5 mM thymidine overnight ( 18 h). Cells 
were released into S phase and through mitosis by adding 10% FCS medium 
(with or without 100 nM nocodazole as indicated) after three washes in 
warm medium. Cells were collected by trypsinization at various time points 
and split into samples for Western blotting and ﬂ  ow cytometry.
siRNA transfections
siRNAs (21-mers) targeting GFP, Cdh1, securin, and cyclin B (siGENOME; 
Dharmacon) were used to reduce protein expression in KB cells. Cells were 
transfected using LipofectAMINE 2000 (12 μl/10-cm dish; Invitrogen) with 
siRNA (10 pM cyclin B1/securin-speciﬁ   c siRNA, 5 nM Cdh1-speciﬁ  c 
siRNA, and GFP-speciﬁ  c siRNA up to 20 nM total siRNA concentration or 
20 nM GFP-speciﬁ  c siRNA alone). Complexes were incubated for 20 min 
at RT before adding to cells for 24 h.
Immunoprecipitations and kinase assays
Cell lysates were subjected to immunoprecipitation followed by histone H1 
kinase assay or Western blotting. IME or KB cells were lysed in lysis buffer 
(50 mM Tris, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100 detergent, and 
phosphatase/protease inhibitors) on ice, sonicated, and cleared for 10 
min at 10,000 g at 4°C, and protein concentrations were determined us-
ing a Bradford solution (Bio-Rad Laboratories) read at 595 nM. For kinase 
assays, 7.5 μg anti-Cdk2 or IgG1 antibody was added to the lysates with 
γ-bind G Sepharose beads (100 μl of a 50% slurry; GE Healthcare) for 
2 h at 4°C. Beads were washed three to ﬁ  ve times with lysis buffer and twice 
with 1× reaction buffer (without ATP). Beads were resuspended in 2× re-
action buffer (40 mM Tris-HCl, pH 7.5, and 15 mM MgCl2), 20 μM ATP, 
20 μg histone H1, and 10 μCi γ-[
32P]ATP and incubated for 30 min at 
37°C. Samples were prepared and run on an 11% SDS-PAGE gel, and 
autoradiography was performed or phosphorylation was quantiﬁ  ed using 
a phosphorimager (Storm 840; Molecular Dynamics).
Cdh1 kinase assays were performed with 2 μg E. coli–puriﬁ  ed GST-
Cdh1 as a substrate in the kinase reaction. 10 μg GST peptide alone and 
2 μg histone H1 kinase assays were used to compared cyclin E/Cdk2 
  kinase activity.
GST puriﬁ  cation of Cdh1 and expression of myc-tagged Cdh1
GST-Cdh1-WT (a gift from C. Sorensen, Danish Cancer Society, Institute of 
Cancer Biology, Copenhagen, Denmark) had been cloned into the GST-
2TK plasmid (GE Healthcare). The fusion protein was expressed in E. coli 
bacteria after induction with IPTG, bound to glutathione–Sepharose beads, 
and eluted with reduced glutathione. The washes and eluted fractions 
were run on an SDS-PAGE gel and stained with Coomassie to evaluate pu-
rity. GST-Cdh1 was observed running at 75 kD with degradation bands 
running below.
Myc-tagged Cdh1 constructs (WT, AAA, and 4A or empty vector 
pX-myc; gifts from C. Sorensen), which were described previously (Sorensen 
et al., 2001), were expressed in 293T cells along with puriﬁ  ed cyclin E or 
cyclin A using calcium-phosphate transfections and were collected after 48 h 
of transfection. 9E10 anti-myc antibody (Sigma-Aldrich) was used for 
immunoprecipitation. Beads were boiled in SDS-running buffer and analyzed 
by Western blotting. Whole cell lysates and IPs were immunoblotted for 
cyclin E, cyclin A, or Cdh1.
Cdc27 immunoprecipitations. KB cells were transfected with plas-
mid expressing myc-tagged Cdh1. 24 h later, cells were transduced with 
cyclin E–expressing or control adenovirus and subjected to a single thymi-
dine block for 17 h followed by release for 4 h and harvest. Cell pellets 
were lysed in 50 mM β-glycerophosphate, 5 mM EDTA, 100 mM NaCl, 
0.1% Triton X-100, and 1 mM DTT plus protease and phosphatase inhibi-
tors and were cleared by spinning at 15,000 g for 15 min. 700 μg lysate 
was incubated for 1 h with protein A beads coupled to polyclonal anti-
bodies against Cdc27 and then washed three times with lysis buffer. Pre-
cipitated proteins were eluted with SDS sample buffer and resolved along 
with input (50 μg lysates) by SDS-PAGE, transferred to polyvinylidene di-
ﬂ  uoride membranes, and probed with monoclonal antibodies to Cdh1 
(Neomarkers) and Cdc27 (Becton Dickinson). Band densities were measured JCB • VOLUME 178 • NUMBER 3 • 2007  384
with ImageJ software (National Institutes of Health), and ratios of Cdh1/
Cdc27 precipitated in each sample were determined and set to 1.0 for the 
control sample.
Ubiquitylation assays
For kinase inhibition of Cdh1, 2 μl Cdh1 proteins generated with the TNT 
Quick Coupled Transcription/Translation kit (Promega) with or without 
 40 ng cyclin–Cdk2 complexes were diluted in kinase buffer (50 mM 
Tris, pH 7.5, 10 mM MgCl2, 2 mM DTT, 200 μM ATP, 5 μM okadaic acid, 
and 1 mM EGTA) to a ﬁ  nal reaction volume of 10 μl and incubated at 
30°C for 1 h. 100 nM purvalanol A was added to the kinase reactions 
  either before the addition of Cdh1 (with a 15-min preincubation at 30°C) 
or at the end of the reaction with an additional 15-min incubation to 
quench the kinase activity.
Anti-Cdc27 polyclonal antibodies coupled to an Afﬁ  prep  support 
(Bio-Rad Laboratories) were used to precipitate the APC from interphase 
Xenopus laevis egg extracts. The beads were washed four times in buffer 
XB
− (20 mM Hepes, pH 7.7, and 100 mM KCl) supplemented with 0.5% 
NP-40 and 400 mM KCl and then were washed twice in XB
−. Cdh1 pro-
teins were then added to the APC beads and incubated at 4°C for 30 min. 
The beads were washed twice in XB
− and resuspended in 5 μl of reaction 
cocktail (20 ng E1, 100 ng UbcH10, and 1.25 μg ubiquitin)/μl in XB
− sup-
plemented with an energy regenerating system and 1 μl 
35S-labeled cyclin B1 
N-terminal fragment. The reactions were incubated at RT, and samples were 
taken at the indicated times, resolved by SDS-PAGE, and imaged using a 
phosphorimager (Typhoon; Molecular Dynamics). Densitometry was per-
formed on the nonmodiﬁ  ed substrate using ImageQuant software (Molecular 
Dynamics). Data was normalized to input and control reactions.
Online supplemental material
Video 1 shows the cyclin E–mediated early mitotic delay presented in Fig. 
3 c. Video 2 presents cyclin E–mediated early mitotic delay shown by live 
cell microscopy in a U2OS cell. Video 3 shows cyclin E–mediated mitotic 
failure in a U2OS cell. Fig. S1 shows cell cycle analysis of adenovirally 
expressed cyclin E. Fig. S2 shows a comparison of cyclin E levels during the 
cell cycle between adenovirally transduced cell lines used in this study and 
breast cancer–derived cell lines expressing high levels of cyclin E. Fig. S3 
shows an analysis of the cyclin E–mediated accumulation of polyploidy cells 
during one cell cycle equivalent. Online supplemental material is available 
at http://www.jcb.org/cgi/content/full/jcb.200703202/DC1.
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